Jazz Pharmaceuticals Return On Equity vs. Shares Owned By Insiders

JAZZ Stock  USD 108.79  2.34  2.20%   
Based on Jazz Pharmaceuticals' profitability indicators, Jazz Pharmaceuticals PLC is performing exceptionally good at this time. It has a great probability to showcase excellent profitability results in October. Profitability indicators assess Jazz Pharmaceuticals' ability to earn profits and add value for shareholders.
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
0.11100678
Current Value
0.22
Quarterly Volatility
0.22084778
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, Jazz Pharmaceuticals' EV To Sales is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 0.39 in 2024, whereas Price To Sales Ratio is likely to drop 1.93 in 2024. At this time, Jazz Pharmaceuticals' Operating Income is fairly stable compared to the past year. Net Income is likely to rise to about 435.6 M in 2024, despite the fact that Accumulated Other Comprehensive Income is likely to grow to (799.6 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.70.7278
Sufficiently Down
Slightly volatile
For Jazz Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Jazz Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Jazz Pharmaceuticals PLC utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Jazz Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Jazz Pharmaceuticals PLC over time as well as its relative position and ranking within its peers.
  

Jazz Pharmaceuticals' Revenue Breakdown by Earning Segment

Check out Risk vs Return Analysis.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Jazz Pharmaceuticals. If investors know Jazz will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Jazz Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.643
Earnings Share
5.9
Revenue Per Share
62.285
Quarterly Revenue Growth
0.069
Return On Assets
0.0429
The market value of Jazz Pharmaceuticals PLC is measured differently than its book value, which is the value of Jazz that is recorded on the company's balance sheet. Investors also form their own opinion of Jazz Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Jazz Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Jazz Pharmaceuticals' market value can be influenced by many factors that don't directly affect Jazz Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Jazz Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Jazz Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Jazz Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Jazz Pharmaceuticals PLC Shares Owned By Insiders vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Jazz Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Jazz Pharmaceuticals value to that of its competitors to determine the firm's financial worth.
Jazz Pharmaceuticals PLC is rated fifth overall in return on equity category among its peers. It is rated below average in shares owned by insiders category among its peers making about  26.57  of Shares Owned By Insiders per Return On Equity. At this time, Jazz Pharmaceuticals' Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Jazz Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Jazz Pharmaceuticals' Earnings Breakdown by Geography

Jazz Shares Owned By Insiders vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Jazz Pharmaceuticals

Return On Equity

 = 

Net Income

Total Equity

 = 
0.11
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Jazz Pharmaceuticals

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
2.88 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.

Jazz Shares Owned By Insiders Comparison

Jazz Pharmaceuticals is currently under evaluation in shares owned by insiders category among its peers.

Jazz Pharmaceuticals Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Jazz Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Jazz Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Jazz Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Jazz Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-841.7 M-799.6 M
Operating Income659.3 M692.2 M
Net Income414.8 M435.6 M
Income Tax Expense-119.9 M-113.9 M
Income Before Tax297.9 M161.9 M
Total Other Income Expense Net-361.4 M-343.3 M
Net Loss-201.7 M-191.6 M
Net Income From Continuing Ops80 M151.3 M
Non Operating Income Net Other-26 M-24.7 M
Interest Income94.5 M81.7 M
Net Interest Income-293.2 M-278.6 M
Change To Netincome160 M90.9 M
Net Income Per Share 6.55  6.88 
Income Quality 2.63  1.36 
Net Income Per E B T 1.39  0.86 

Jazz Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Jazz Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Jazz Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Jazz Pharmaceuticals' important profitability drivers and their relationship over time.

Use Jazz Pharmaceuticals in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Jazz Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jazz Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Jazz Pharmaceuticals Pair Trading

Jazz Pharmaceuticals PLC Pair Trading Analysis

The ability to find closely correlated positions to Jazz Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Jazz Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Jazz Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Jazz Pharmaceuticals PLC to buy it.
The correlation of Jazz Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Jazz Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Jazz Pharmaceuticals PLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Jazz Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Jazz Pharmaceuticals position

In addition to having Jazz Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Obamacare Thematic Idea Now

Obamacare
Obamacare Theme
Health care services and providers including hospitals, clinics and nursing homes that hope to benefit from Obamacare program. The Obamacare theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Obamacare Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Jazz Stock Analysis

When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.